首页|芪参益气滴丸联合常规西医治疗慢性心力衰竭患者的效果

芪参益气滴丸联合常规西医治疗慢性心力衰竭患者的效果

扫码查看
目的:观察芪参益气滴丸联合常规西药治疗慢性心力衰竭(CHF)患者的效果.方法:选取 2022 年 1 月至 2023 年 6 月该院收治的 74 例CHF患者进行前瞻性研究,按随机数字表法将其分为对照组与研究组各 37 例.对照组采用常规西医治疗,研究组在对照组基础上联合芪参益气滴丸治疗.比较两组临床疗效,治疗前后心功能指标[左心室射血分数(LVEF)、左心室短轴缩短率(LVFS)、左心室收缩末期内径(LVESD)、左心室舒张末期内径(LVEDD)]、心肌损伤标志物[心肌型脂肪酸结合蛋白(hFABP)、N-末端脑钠肽前体(NT-proBNP)、半乳糖凝聚素-3(Gal-3)]水平,以及不良反应发生率.结果:研究组治疗总有效率为 94.59%,高于对照组的78.38%,差异有统计学意义(P<0.05);治疗后,两组LVEF、LVFS水平均高于治疗前,且研究组高于对照组,两组LVEDD、LVESD水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);两组NT-proBNP、hFABP、Gal-3 水平均低于治疗前,且研究组低于对照组,差异有统计学意义(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05).结论:芪参益气滴丸联合常规西医治疗CHF患者可提高治疗总有效率,改善心功能指标水平,降低心肌损伤标志物水平,其效果优于单纯常规西医治疗.
Effects of Qishen Yiqi dropping pills combined with conventional western medicine in treatment of patients with chronic heart failure
Objective:To observe effects of Qishen Yiqi dropping pills combined with conventional western medicine in treatment of patients with chronic heart failure(CHF).Methods:A prospective study was conducted on 74 patients with CHF admitted to this hospital from January 2022 to June 2023.According to the random number table method,they were divided into control group and study group,37 cases in each group.The control group was treated with conventional western medicine,while the study group was treated with Qishen Yiqi dropping pills on the basis of that of the control group.The clinical efficacy,the cardiac function indexes[left ventricular ejection fraction(LVEF),left ventricular fractional shortening(LVFS),left ventricular end-systolic diameter(LVESD),left ventricular end-diastolic diameter(LVEDD)],the myocardial injury markers[heart-type fatty acid binding protein(hFABP),N-terminal pro-brain natriuretic peptide(NT-proBNP),galectin-3(Gal-3)]levels before and after the treatment,and the incidence of adverse reactions were compared between the two groups.Results:The total effective rate of treatment in the study group was 94.59%,which was higher than 78.38%in the control group,and the difference was statistically significant(P<0.05).After the treatment,the levels of LVEF and LVFS in the two groups were higher than those before the treatment,and those in the study group were higher than those in the control group;the LVEDD and LVESD of the two groups were lower than those before the treatment,and those in the study group were lower than those in the control group;and the differences were statistically significant(P<0.05).After the treatment,the levels of NT-proBNP,hFABP and Gal-3 in the two groups were lower than those before the treatment,those in the study group were lower than those in the control group,and the differences were statistically significant(P<0.05).However,there was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusions:Qishen Yiqi dropping pills combined with conventional western medicine in the treatment of the CHF patients can improve the total effective rate of treatment,improve the levels of cardiac function indexes,and reduce the levels of myocardial injury markers.Moreover,it is superior to simple conventional western medicine treatment.

Qishen Yiqi dropping pillsChronic heart failureCardiac functionMyocardial injuryAdverse reaction

连兰峰、孔春灵、孟祥旭、张淑、赵昂

展开 >

河南大学第一附属医院心血管内科,河南 开封 475000

芪参益气滴丸 慢性心力衰竭 心功能 心肌损伤 不良反应

河南省医学科技攻关计划项目

LHGJ20220645

2024

中国民康医学
中国社会工作协会

中国民康医学

影响因子:0.649
ISSN:1672-0369
年,卷(期):2024.36(16)
  • 14